Skip to main content

Part of UT Health San Antonio

Office of the Vice President for Research - UT Health San Antonio Office of the Vice President for Research - UT Health San Antonio

Part of UT Health San Antonio

Researcher Quicklinks

Institutional Core Labs

  • iLabs
  • Bioanalytics & Single-Cell
  • Biospecimen and Translational Genomics
  • Flow Cytometry
  • Mass Spectometry
  • Optical Imaging
  • Structural Biology (NMR)
  • Structural Biology (X-Ray Crystallography)

Find a Researcher

  • Profiles

Research by School

  • Long School of Medicine
  • School of Dentistry
  • School of Health Professions
  • School of Nursing

Software Training & Cyberinfrastructure

  • VPR IT

Additional Resources

  • Environmental Health & Safety
  • Council of Principal Investigators
  • National Academy of Inventors
  • Office of Technology Commercialization
  • Postdoc Positions
  • Report A Discovery
  • Research Directory
  • San Antonio Bioscience Research
  • San Antonio Partnership for Precision Therapeutics
  • Spotlight on Research Integrity

Close Quicklinks

Menu
  • Home
  • Funding
  • Collaborations
  • Core Labs
  • Responsible Conduct of Research
  • Services
  • Research Areas
  • Researchers

3/16/20: Investigators Conducting Human Subjects Research

Investigators conducting human subjects research: 

We anticipate that human subjects research will be impacted by the COVID-19 pandemic. As part of your due diligence, please prepare for impact on normal operations. We will continue to provide updates/policy modifications specific to human subjects research as they become available. 

In order to: i) mitigate the risk for both employees and research participants, ii) ensure that providers are available to perform clinical duties, and iii) preserve personal protective equipment for clinical care, we request that you consider the following with regard to your current research projects involving direct contact with research participants.  

While human subjects research is not being restricted unilaterally, all PIs must review their protocols to determine whether a pause in research activity may be warranted. We will evaluate the need for further restrictions in the coming days based on the evolving conditions. 

Continuation of the following types of studies is deemed appropriate: 

  • therapeutic research wherein there are limited/no treatment alternatives,  
  • FDA "Treatment" or "Emergency Use" studies, 
  • studies in which interruption/delay of research could cause significant harm to current research subjects. 

For the continuation of all other types of human subject research, the PI must obtain permission from the appropriate departmental chair or center/institute director. Determinations to continue studies must be in alignment with both the ethical principles of human subject research and the safety of employees. We strongly recommend documenting these decisions.

In making a decision to proceed with human subjects research, we recommend the following considerations.  

  • Is the risk/benefit ratio for in-person contact acceptable? 
  • Does the study provide direct drug or device therapeutic benefit? 
  • Is any travel required of participants or employees appropriate, given current travel restrictions?  
  • Can study procedures be modified to minimize in-person contact (e.g., remote data collection)?  
  • If the study proceeds, what modifications are necessary to mitigate risk to human subjects and employees (note, there are currently restrictions on PPE for research).  
  • Is it necessary to pursue new enrollments? Follow-up visits? 
  • Note, please review the posted IRB guidance to determine how and when changes should be reported to IRB.  (Please review the COVID-19 guidance on IRB review at: http://research.uthscsa.edu/irb/COVID.pdf) 
  • If you have questions or would like additional consultation in making a determination as it relates to protecting human subjects or IRB responsibilities, please contact Dr. Joseph Schmelz (schmelz@uthscsa.edu ) or Dr. Kimberly Summers (summers@uthscsa.edu) 210-854-5671.

For questions or information related to departmental chair or center/institute director approval for research continuation please contact your respective Research Dean.

SOM- Dr. Jennifer Potter (potterjs@uthscsa.edu)

SOD- Dr. Brij Singh (singhbb@uthscsa.edu) 

SON- Dr. Jing Wang (wangj1@uthscsa.edu)

SHP- Dr. Timothy Reistetter (reistetter@uthscsa.edu) 

 

Map image of UT Health San Antonio location

UT Health San Antonio

8403 Floyd Curl Dr
San Antonio, TX 78229

210-567-8270
vpr@uthscsa.edu

Connect with us

  • Twitter
  • YouTube
  • Linked In
  • Job Opportunities
  • Research Directory
  • Give a Donation

We make lives better ®

The University of Texas Health Science Center at San Antonio, also called UT Health San Antonio, is a leading academic health center with a mission to make lives better through excellence in advanced academics, life-saving research and comprehensive clinical care including health, dental and cancer services.

Web Privacy | Links from websites affiliated with UT Health's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.